HBC THERAPEUTICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: JO
Jon Olav Ødegård1973
Chairman of the board: JO
Jon Olav Ødegård1973
Years since formation: 6 years; since Mar 7, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 20,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Annual total result 2023: -22,162; NOK
Total equity 2023: -289,271; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
JO Jon Olav Ødegård 1973	Managing Director/CEO	-

Board

Name	Role	Shares
JO Jon Olav Ødegård 1973	Chairman	-

Top 10 individual shareholders

Name	Role	Shares
RH Roger Hofseth 1974	-	23.4 % indirectly
BP Bomi Patel-Framroze 1961	-	1.09 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
H HOFSETH BIOCARE ASA	Ordinary shares	20,000	100 %

Last update: May 24, 2024

Group structure

HOFSETH BIOCARE ASA
Total operating income 2023: NOK 218,418,000
Operating profit 2023: NOK -86,445,000
Employees: 72

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	28,284
Annual Total Result	-22,162	-265,860	-308,218
Total assets	7,630	11,535	229,565
Total liabilities	296,902	278,645	230,815
Total equity	-289,271	-267,110	-1,250

P&L

Year	2023	2022	2021
Total operating income	0	0	28,284
Total operating costs	22,162	265,795	313,670
Operating result	-22,162	-265,795	-285,386
Financial income/costs	0	-65	-22,832
Profit before tax	-22,162	-265,860	-308,218
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-22,162	-265,860	-308,218

Balance overview

Year	2023	2022	2021
Total fixed assets	0	0	188,181
Total current assets	7,630	11,535	41,384
Total assets	7,630	11,535	229,565
Short term debt	296,902	278,645	230,815
Long term debt	0	0	0
Total liabilities	296,902	278,645	230,815
Contributed capital	5,194,430	5,194,430	5,194,430
Retained earnings	-5,483,701	-5,461,540	-5,195,680
Total equity	-289,271	-267,110	-1,250
Total equity and liabilities	7,630	11,535	229,565

HBC THERAPEUTICS AS920 475 272